Biomet Inc – ‘10-K405’ for 5/31/00 – EX-27.1

On:  Thursday, 8/10/00, at 1:38pm ET   ·   For:  5/31/00   ·   Accession #:  950137-0-3569   ·   File #:  1-15601

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report — [x] Reg. S-K Item 405   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K405     Annual Report                                         49    311K 
 2: EX-21.1     Subsidiaries of the Registrant                         2     10K 
 3: EX-23.1     Consent of Pricewaterhousecoopers LLP                  1      6K 
 4: EX-27.1     Financial Data Schedule                                1      6K 

EX-27.1   —   Financial Data Schedule

                                                                [Download Table]
                                                      

<ARTICLE> 5                                           

                                                      
<PERIOD-TYPE>                   12-MOS                
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-END>                               MAY-31-2000
<CASH>                                     213,606,000
<SECURITIES>                                34,129,000
<RECEIVABLES>                              258,033,000
<ALLOWANCES>                                 8,241,000
<INVENTORY>                                240,162,000
<CURRENT-ASSETS>                           789,628,000
<PP&E>                                     299,294,000
<DEPRECIATION>                             116,037,000
<TOTAL-ASSETS>                           1,218,448,000
<CURRENT-LIABILITIES>                      181,443,000
<BONDS>                                     85,086,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                 943,323,000
<TOTAL-LIABILITY-AND-EQUITY>             1,218,448,000
<SALES>                                    920,582,000
<TOTAL-REVENUES>                           920,582,000
<CGS>                                      278,382,000
<TOTAL-COSTS>                              656,908,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           3,193,000
<INCOME-PRETAX>                            280,692,000
<INCOME-TAX>                                99,738,000
<INCOME-CONTINUING>                        173,771,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               173,771,000
<EPS-BASIC>                                       0.99
<EPS-DILUTED>                                     0.98